Requirements for prescriptions to be dispensed in an EEA state other than the UK217A

1

In this regulation—

• “B” means a person who is an appropriate practitioner for the purposes of regulation 214(3) to (5B);

• “P” means a person who is the patient of B.

2

The information specified in paragraph (3) is to be included in any prescription where—

a

P requests a prescription that is to be dispensed in an EEA state other than UK; and

b

B determines that such a prescription is appropriate.

3

The specified information is—

a

the patient’s—

i

surname,

ii

first names written out in full, and

iii

date of birth;

b

the issue date of the prescription;

c

B’s—

i

surname,

ii

first names written out in full,

iii

professional qualification,

iv

direct contact details including—

aa

email address,

bb

telephone or fax number with the appropriate international prefix,

v

work address,

vi

confirmation that B works as a health professional in the UK, and

vii

electronic signature or a signature written in ink;

d

details about the prescribed product, including where applicable the—

i

common name of the product as defined by Article 1 of the 2001 Directive,

ii

brand name if—

aa

the prescribed product is a biological medicinal product, or

bb

B deems it medically necessary for that product to be dispensed and B’s reasons justifying the use of the branded product,

iii

pharmaceutical formulation (tablet, solution, etc.),

iv

quantity,

v

strength of the medicinal product as defined in Article 1 of the 2001 Directive, and

vi

dosage regimen.

4

A prescription under this regulation may only be issued by B in relation to those products that B is authorised to prescribe under regulation 214(3) to (5B).